clopidogrel taw pharma (previously clopidogrel mylan)
taw pharma (ireland) limited - klopidogrela hidrohlorīds - peripheral vascular diseases; stroke; myocardial infarction; acute coronary syndrome - antitrombotiskie līdzekļi - , , , , secondary prevention of atherothrombotic events, , clopidogrel is indicated in: , - adult patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease. , - adult patients suffering from acute coronary syndrome:, - non-st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa). , - st segment elevation acute myocardial infarction, in combination with asa in medically treated patients eligible for thrombolytic therapy. , , in patients with moderate to high-risk transient ischaemic attack (tia) or minor ischaemic stroke (is), clopidogrel in combination with asa is indicated in:, - adult patients with moderate to high-risk tia (abcd2 score ≥4) or minor is (nihss ≤3) within 24 hours of either the tia or is event. , , prevention of atherothrombotic and thromboembolic events in atrial fibrillation, in adult patients with atrial fibrillation who have at least one risk factor for vascular events, are not suitable for treatment with vitamin k antagonists (vka) and who have a low bleeding risk, clopidogrel is indicated in combination with asa for the prevention of atherothrombotic and thromboembolic events, including stroke. , , for further information please refer to section 5. , , ,.
nyxoid
mundipharma corporation (ireland) limited - naloksona hidrohlorīdu dihidrāts - ar opioīdiem saistītas slimības - visi pārējie terapeitiskie produkti - nyxoid domāta tiešā pārvalde kā ārkārtas terapiju par zināmajiem vai aizdomās opioīdu pārdozēšanas kā izpaudās ar elpošanas un/vai centrālās nervu sistēmas depresija nav medicīnas un veselības aprūpes uzstādījumi. nyxoid is indicated in adults and adolescents aged 14 years and over. nyxoid is not a substitute for emergency medical care.
adenosin life medical 5 mg/ml šķīdums injekcijām/infūzijām
life medical sweden ab, sweden - adenozīns - Šķīdums injekcijām/infūzijām - 5 mg/ml
rienso
takeda pharma a/s - ferumoksitols - anemia; kidney failure, chronic - citi antianēmiskie līdzekļi - rienso ir indicēts dzelzs deficīta anēmijas intravenozai ārstēšanai pieaugušiem pacientiem ar hronisku nieru slimību (ckd). diagnozi par dzelzs deficītu, ir jābūt balstītai uz atbilstošu laboratorijas testu (skatīt 4. iedaļu.
multibic ar kāliju 2 mmol/l šķīdums hemodialīzei/hemofiltrācijai
fresenius medical care deutschland gmbh, germany - natrii chloridum, kalii chloridum, natrii hydrogenocarbonas, kalcija chloridum dihydricum, magnija chloridum hexahydricum, glikozes monohydricum - Šķīdums hemodialīzei/hemofiltrācijai
multibic bez kālija šķīdums hemodialīzei/hemofiltrācijai
fresenius medical care deutschland gmbh, germany - natrii chloridum, natrii hydrogenocarbonas, kalcija chloridum dihydricum, magnija chloridum hexahydricum, glikozes monohydricum - Šķīdums hemodialīzei/hemofiltrācijai
multibic ar kāliju 4 mmol/l šķīdums hemodialīzei/hemofiltrācijai
fresenius medical care deutschland gmbh, germany - natrii chloridum, kalii chloridum, natrii hydrogenocarbonas, kalcija chloridum dihydricum, magnija chloridum hexahydricum, glikozes monohydricum - Šķīdums hemodialīzei/hemofiltrācijai
multibic ar kāliju 3 mmol/l šķīdums hemodialīzei/hemofiltrācijai
fresenius medical care deutschland gmbh, germany - natrii chloridum, kalii chloridum, natrii hydrogenocarbonas, kalcija chloridum dihydricum, magnija chloridum hexahydricum, glikozes monohydricum - Šķīdums hemodialīzei/hemofiltrācijai
bicavera 4,25% glikoze, 1,25 mmol/l kalcijs, šķīdums peritoneālai dialīzei
fresenius medical care deutschland gmbh, germany - kalcija chloridum dihydricum, glikozes monohydricum, magnija chloridum hexahydricum, natrii chloridum, natrii hydrogenocarbonas - Šķīdums peritoneālai dialīzei - 4,25%/1,25 mmol/l
balance 1,5% glikoze, 1,25 mmol/l kalcijs, šķīdums peritoneālai dialīzei
fresenius medical care deutschland gmbh, germany - kalcija chloridum dihydricum, glikozes monohydricum, magnija chloridum hexahydricum, natrii chloridum, natrii lactatis risinājums - Šķīdums peritoneālai dialīzei